This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Lindsay Goldberg gets EU approval to buy pharma-packaging supplier Bilcare Research

( October 28, 2019, 13:40 GMT | Official Statement) -- MLex Summary: Plans by New York-based private-equity firm Lindsay Goldberg to acquire Bilcare Research, a Swiss supplier of technical plastic films used in the manufacture of flexible packaging, notably for the pharmaceutical industry, won European Commission approval today. The deal doesn't trigger any antitrust concerns, the commission concluded, given the “limited horizontal overlaps and vertical relationships between the companies' activities.”Statement follows. Mergers: Commission clears acquisition of Bilcare Research Group by Lindsay Goldberg The European Commission has approved, under the EU Merger Regulation, the acquisition of Bilcare Research Group of Switzerland by Lindsay Goldberg of the US. Bilcare Research Group is a global manufacturer and supplier of technical plastic films that are used for the production of flexible packaging as well as for non-packaging applications. Lindsay Goldberg manages different funds that hold equity investments in operating portfolio companies. The Commission concluded that the proposed acquisition would raise no competition concerns given the limited horizontal overlaps and vertical relationships between the companies' activities. The operation was examined under the normal merger review procedure. More information will be available on the Commission's competition website, in the public case register under the case number M.9500....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login